Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn's disease in different treatments

BMC Gastroenterol. 2022 May 18;22(1):250. doi: 10.1186/s12876-022-02327-5.

Abstract

Background and aims: It is crucial to manage the recurrence of Crohn's disease (CD). This study is aimed to explore whether visceral adipose tissue (VAT) and skeletal muscle (SM) are associated with the recurrence of CD upon different treatments.

Methods: All patients with a definite diagnosis of CD were retrospectively divided into three groups according to distinct treatment regimens: 5-amino salicylic acid group (Group A), steroids + azathioprine (Group B) and biologics (Group C). The pretreatment computerized tomography (CT) images and clinical data were collected. The VAT area, mesenteric fat index (MFI), the ratio of VAT area to fat mass (VAT area/FM) were assessed. The primary end point was the recurrence of CD within 1 year of follow-up.

Results: A total of 171 CD patients were enrolled, including 57 (33.33%) patients in Group A, 70 (40.94%) patients in Group B and 44 (25.73%) patients in Group C. Patients with 1-year recurrence had higher MFI (P = 0.011) and VAT area/FM (P = 0.000). ROC curve demonstrated that patients with the ratio of VAT area/FM and MFI higher than 0.578 and 1.394 tended to have recurrence with the AUC of 0.707 and 0.709. Similar results could be observed in Group A & B but not in Group C.

Conclusions: High VAT area/FM and MFI are related to recurrence within 1 year for newly diagnosed CD patients treated by 5-amino salicylic or azathioprine + steroids rather than biologics. We could not observe any radiological data associated with the recurrence of CD patients under biological treatment.

Keywords: Crohn’s disease; Skeletal muscle; Visceral adipose tissue.

MeSH terms

  • Adipose Tissue
  • Azathioprine / therapeutic use
  • Biological Products*
  • Crohn Disease* / diagnostic imaging
  • Crohn Disease* / drug therapy
  • Humans
  • Intra-Abdominal Fat / diagnostic imaging
  • Muscle, Skeletal
  • Retrospective Studies

Substances

  • Biological Products
  • Azathioprine